Description: Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Home Page: www.alfresa.com
1-1-3 Otemachi
Tokyo,
100-0004
Japan
Phone:
81 3 5219 5100
Officers
| Name | Title |
|---|---|
| Mr. Ryuji Arakawa | Pres & Representative Director |
| Toshiki Tanaka | VP, Exec. Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & Dir |
| Mr. Seiichi Kishida | Deputy Pres, Assistant to the Pres for Fin Planning and Corp. Communication & Director |
| Mr. Yusuke Fukujin | Deputy Pres & Director |
| Shigeki Ohashi | VP, Exe. Officer of Grp Bus, Affiliate Control, Bus Dev & International Bus. and Director |
| Kazuaki Hano | Exec. Officer |
| Soichi Nemoto | Exec. Officer |
| Toshikazu Urakabe | Exec. Officer |
| Takashi Sasaki | Exec. Officer |
Exchange: OTCGREY
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 10.5982 |
| Price-to-Book MRQ: | 0.5814 |
| Price-to-Sales TTM: | 0.0008 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 11925 |